The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots

Proteomics

Volumn 10, Issue 18, 2010, Pages 3356-3366

  Peinado, Juan R ^a,b   Jimenez Gomez, Yolanda ^a,b   Pulido, Marina R ^a,b   Ortega Bellido, Maria ^a,b   Diaz Lopez, Cesar ^c   Padillo, Francisco J ^c   Lopez Miranda, Jose ^a,c   Vazquez Martínez, Rafael ^a,b   Malagón, María M ^a,b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

2 D PAGE; Adipose tissue; Cell biology; Mature adipocytes; Stromal vascular fraction

Indexed keywords

ALDEHYDE DEHYDROGENASE; EZRIN; LAMIN A; LAMIN C; RETINOIC ACID;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; FEMALE; HUMAN; IMMUNOBLOTTING; LIPODYSTROPHY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

AGED; GENE EXPRESSION REGULATION; HUMANS; INTRA-ABDOMINAL FAT; MIDDLE AGED; RNA, MESSENGER; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 77956517294     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000350     Document Type: Article

References (40)

1. Kershaw, E. E., Flier, J. S., Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548-2556.
2. Frayn, K. N., Karpe, F., Fielding, B. A., Macdonald, I. A., Coppack, S. W., Integrative physiology of human adipose tissue. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 875-888. (Pubitemid 36918608)
3. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., Bahouth, S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145, 2273-2282.
4. Zeyda, M., Farmer, D., Todoric, J., Aszmann, O. et al., Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. 2007, 31, 1420-1428.
5. Shoelson, S. E., Lee, J., Goldfine, A. B., Inflammation and insulin resistance. J. Clin. Invest. 2006, 116, 1793-1801.
6. Wajchenberg, B. L., Giannella-Neto, D., da Silva, M. E., Santos, R. F., Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm. Metab. Res. 2002, 34, 616-621.
7. Hamdy, O., Porramatikul, S., Al-Ozairi, E., Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr. Diab. Rev. 2006, 2, 367-373.
8. Araujo-Vilar, D., Lattanzi, G., Gonzalez-Mendez, B., Costa-Freitas, A. T. et al., Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. J. Med. Genet. 2009, 46, 40-48.
9. Mastro, R., Hall, M., Protein delipidation and precipitation by tri-n-butylphosphate, acetone, and methanol treatment for isoelectric focusing and two-dimensional gel electrophoresis. Anal. Biochem. 1999, 273, 313-315.
10. Chen, X., Hess, S., Adipose proteome analysis: focus on mediators of insulin resistance. Expert Rev. Proteomics 2008, 5, 827-839.
11. Gesta, S., Bluher, M., Yamamoto, Y., Norris, A. W. et al., Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. USA 2006, 103, 6676-6681.
12. Niesler, C. U., Siddle, K., Prins, J. B., Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 1998, 47, 1365-1368. (Pubitemid 28357020)
13. Van Harmelen, V., Rohrig, K., Hauner, H., Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 2004, 53, 632-637.
14. Boden, G., Duan, X., Homko, C., Molina, E. J. et al., Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008, 57, 2438-2444.
15. Ahmed, M., Neville, M. J., Edelmann, M. J., Kessler, B. M., Karpe, F., Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity 2010, 18, 27-34.
16. Perez-Perez, R., Ortega-Delgado, F. J., Garcia-Santos, E., Lopez, J. A. et al., Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J. Proteome Res. 2009, 8, 1682-1693.
17. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K. et al., Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307, 426-430. (Pubitemid 40139988)
18. Fain, J. N., Buehrer, B., Bahouth, S. W., Tichansky, D. S., Madan, A. K., Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism 2008, 57, 1005-1015.
19. Schaffler, A., Neumeier, M., Herfarth, H., Furst, A. et al., Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta 2005, 1732, 96-102. (Pubitemid 43267310)
20. Berndt, J., Kloting, N., Kralisch, S., Kovacs, P. et al., Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005, 54, 2911-2916.
21. Garg, A., Agarwal, A. K., Lipodystrophies: Disorders of adipose tissue biology. Biochim. Biophys. Acta 2009, 1791, 507-513.
22. Miranda, M., Chacon, M. R., Gutierrez, C., Vilarrasa, N. et al., LMNA mRNA expression is altered in human obesity and type 2 diabetes. Obesity 2008, 16, 1742-1748.
23. Lelliott, C. J., Logie, L., Sewter, C. P., Berger, D. et al., Lamin expression in human adipose cells in relation to anatomical site and differentiation state. J. Clin. Endocrinol. Metab. 2002, 87, 728-734.
24. Wojtanik, K. M., Edgemon, K., Viswanadha, S., Lindsey, B. et al., The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. J. Lipid Res. 2009, 50, 1068-1079.
25. Lloyd, D. J., Trembath, R. C., Shackleton, S., A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum. Mol. Genet. 2002, 11, 769-777.
26. Louvet-Vallee, S., ERM proteins: from cellular architecture to cell signaling. Biol. Cell 2000, 92, 305-316.
27. Barreiro, O., Yanez-Mo, M., Serrador, J. M., Montoya, M. C. et al., Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J. Cell. Biol. 2002, 157, 1233-1245. (Pubitemid 34847793)
28. Koss, M., Pfeiffer, G. R., 2nd , Wang, Y., Thomas, S. T. et al., Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J. Immunol. 2006, 176, 1218-1227.
29. Lim, S., Ryu, J., Shin, J. A., Shin, M. J. et al., Tumor necrosis factor-alpha potentiates RhoA-mediated monocyte transmigratory activity in vivo at a picomolar level. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 2138-2145.
30. Duffaut, C., Zakaroff-Girard, A., Bourlier, V., Decaunes, P. et al., Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 1608-1614.
31. O'Rourke, R. W., Metcalf, M. D., White, A. E., Madala, A. et al., Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int. J. Obes. 2009, 33, 978-990.
32. Harman-Boehm, I., Bluher, M., Redel, H., Sion-Vardy, N. et al., Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J. Clin. Endocrinol. Metab. 2007, 92, 2240-2247.
33. Hotamisligil, G. S., Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
34. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K. et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15, 914-920.
35. Linial, M., Miller, K., Scheller, R. H., VAT-1: an abundant membrane protein from Torpedo cholinergic synaptic vesicles. Neuron 1989, 2, 1265-1273.
36. Kreier, F., Kap, Y. S., Mettenleiter, T. C., van Heijningen, C. et al., Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 2006, 147, 1140-1147.
37. Marchitti, S. A., Brocker, C., Stagos, D., Vasiliou, V., Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 2008, 4, 697-720. (Pubitemid 352003194)
38. Bonet, M. L., Ribot, J., Felipe, F., Palou, A., Vitamin A and the regulation of fat reserves. Cell Mol. Life Sci. 2003, 60, 1311-1321.
39. Adams, M., Montague, C. T., Prins, J. B., Holder, J. C. et al., Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 1997, 100, 3149-3153.
40. Tchkonia, T., Giorgadze, N., Pirtskhalava, T., Thomou, T. et al., Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 2006, 55, 2571-2578.